Dual Antithrombotic Therapy Targeting Residual Risk for Atherosclerotic Cardiovascular Disease Does Body Mass Index Matter?

被引：1
|
作者：
Martin, Karlyn [1 ]
Khan, Sadiya S. [2 ,3 ]
机构：
[1] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 05期
关键词：
anticoagulant; cardiovascular risk; DOAC; obesity; prevention; rivaroxaban; RIVAROXABAN; ASPIRIN; OBESE;
D O I：
10.1016/j.jacc.2020.12.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：526 / 528
页数：3
相关论文
共 50 条
  • [1] Does body mass index of the patients with hypertension affect the risk of cardiovascular disease?
    Arikan, E
    Guldiken, S
    Ugur-Altun, B
    Kara, M
    Tugrul, A
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S114 - S114
  • [2] Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index
    Khera, Rohan
    Pandey, Ambarish
    Ayers, Colby R.
    Carnethon, Mercedes R.
    Greenland, Philip
    Ndumele, Chiadi E.
    Nambi, Vijay
    Seliger, Stephen L.
    Chaves, Paulo H. M.
    Safford, Monika M.
    Cushman, Mary
    Xanthakis, Vanessa
    Ramachandran, Vasan S.
    Mentz, Robert J.
    Correa, Adolfo
    Lloyd-Jones, Donald M.
    Berry, Jarett D.
    de Lemos, James A.
    Neeland, Ian J.
    JAMA NETWORK OPEN, 2020, 3 (10)
  • [3] Targeting Lipoprotein(a) to reduce residual risk in high risk atherosclerotic cardiovascular disease patients
    Waring, Ashley A.
    Morris, Pamela B.
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2023, 52 (02): : 59 - 64
  • [4] Body mass index and screening for cardiovascular disease risk
    Wiwanitkit, Viroj
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2011, 55 (06) : 426 - 426
  • [5] Cardiovascular Disease Risk Reduction and Body Mass Index
    Rohan Samson
    Pierre Vladimir Ennezat
    Thierry H. Le Jemtel
    Suzanne Oparil
    Current Hypertension Reports, 2022, 24 : 535 - 546
  • [6] Cardiovascular Disease Risk Reduction and Body Mass Index
    Samson, Rohan
    Ennezat, Pierre Vladimir
    Le Jemtel, Thierry H.
    Oparil, Suzanne
    CURRENT HYPERTENSION REPORTS, 2022, 24 (11) : 535 - 546
  • [7] Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index
    Arsenault, Benoit J.
    Carpentier, Andre C.
    Poirier, Paul
    Despres, Jean-Pierre
    ATHEROSCLEROSIS, 2024, 394
  • [8] Triglycerides as Residual Risk for Atherosclerotic Cardiovascular Disease
    Ohmura, Hirotoshi
    CIRCULATION JOURNAL, 2019, 83 (05) : 969 - 970
  • [9] Eliminating atherosclerotic cardiovascular disease residual risk
    Makover, Michael E.
    Surma, Stanislaw
    Banach, Maciej
    Toth, Peter P.
    EUROPEAN HEART JOURNAL, 2023, 44 (45) : 4731 - 4733
  • [10] Highlighting Residual Atherosclerotic Cardiovascular Disease Risk
    Matsuura, Yunosuke
    Kanter, Jenny E.
    Bornfeldt, Karin E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (01) : E1 - E9
12345